Avalo Therapeutics, Inc.

AVTX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$134,546$7,415$13,172$54,585
Short-Term Investments$0$0$0$0
Receivables$611$136$1,919$4,799
Inventory$0$0$20$38
Other Curr. Assets$3,733$844$1,305$2,423
Total Curr. Assets$138,890$8,395$16,416$61,845
Property Plant & Equip (Net)$1,209$1,965$2,411$2,695
Goodwill$10,502$10,502$14,409$14,409
Intangibles$0$0$0$38
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$131$131$131$1,227
Total NC Assets$11,842$12,598$16,951$18,369
Other Assets$0$0$0$0
Total Assets$150,732$20,993$33,367$80,214
Liabilities
Payables$283$446$2,882$3,369
Short-Term Debt$568$537$6,462$485
Tax Payable$0$0$0$0
Deferred Revenue$0$0$88$0
Other Curr. Liab.$6,109$3,635$12,682$16,034
Total Curr. Liab.$6,960$4,618$22,114$19,888
LT Debt$0$0$13,486$32,833
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$270$155$141$113
Other NC Liab.$10,470$8,916$8,541$4,298
Total NC Liab.$10,740$9,071$22,168$37,244
Other Liabilities$0$0$0$0
Cap. Leases$568$537$532$485
Total Liabilities$17,700$13,689$44,282$57,132
Equity
Pref Stock$0$0$0$0
Common Stock$10$1$0$9
Retained Earnings-$370,263-$335,134-$303,824-$262,166
AOCI$0$0$0$0
Other Equity$503,285$342,437$292,909$285,239
Total Equity$133,032$7,304-$10,915$23,082
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$150,732$20,993$33,367$80,214
Net Debt-$133,978-$6,878$6,776-$21,267
Avalo Therapeutics, Inc. (AVTX) Financial Statements & Key Stats | AlphaPilot